| Foreword.............................................................................................................................
|
ix |
| Prefact.................................................................................................................................
|
xi |
| |
|
| Chapter 1. Cardiac Tamponade........................................................................................
|
1 |
| Introduction...........................................................................................................................
|
1 |
| Incidence...............................................................................................................................
|
1 |
| Risk Factors..........................................................................................................................
|
2 |
| Pathophysiology....................................................................................................................
|
4 |
| Clinical Manifestations........................................................................................................... |
7 |
| Patient Assessment................................................................................................................
|
10 |
| Diagnostic Evaluation.............................................................................................................
|
12 |
Treatment Modalities..............................................................................................................
|
16 |
| Nursing Management.............................................................................................................
|
24 |
| Patient and Caregiver Educationt.......................................................................................... |
26 |
| Conclusion............................................................................................................................
|
27 |
| References............................................................................................................................
|
27 |
| |
|
| Chapter 2. Disseminated Intravascular Coagulation
..................................................... |
31 |
| Introduction............................................................................................................................
|
31 |
| Incidence................................................................................................................................
|
32 |
| Risk Factors...........................................................................................................................
|
35 |
| Pathophysiology.....................................................................................................................
|
36 |
| Clinical Manifestations............................................................................................................
|
39 |
| Patient Assessment................................................................................................................
|
40 |
| Diagnostic Evaluation.............................................................................................................
|
40 |
| Treatment Modalities..............................................................................................................
|
45 |
| Nursing Management.............................................................................................................
|
47 |
| Patient and Caregiver Education............................................................................................ |
48 |
| Conclusion..............................................................................................................................
|
48 |
| References.............................................................................................................................
|
48 |
| |
|
| Chapter 3. Hypercalcemia of Malignancy.......................................................................... |
51 |
| Introduction.............................................................................................................................
|
51 |
| Incidence.................................................................................................................................
|
51 |
| Risk Factors............................................................................................................................
|
52 |
| Normal Calcium Homeostasis.................................................................................................. |
52 |
| Normal Bone Remodeling and Effects of Metastatic Disease.................................................. |
61 |
| Pathophysiology......................................................................................................................
|
64 |
| Clinical Manifestations............................................................................................................
|
69 |
| Patient Assessment................................................................................................................
|
72 |
| Diagnostic Evaluation.............................................................................................................
|
73 |
| Treatment Modalities...............................................................................................................
|
74 |
| Nursing Management..............................................................................................................
|
90 |
| End-of-Life Considerations..................................................................................................... |
93 |
| Patient and Caregiver Education............................................................................................ |
93 |
| Conclusion..............................................................................................................................
|
94 |
| References.............................................................................................................................
|
94 |
| |
|
| Chapter 4. Increased Intracranial Pressure..................................................................... |
99 |
| Introduction.............................................................................................................................
|
99 |
| Incidence.................................................................................................................................
|
99 |
| Risk Factors............................................................................................................................
|
101 |
| Normal Brain Physiology..........................................................................................................
|
103 |
| Pathophysiology......................................................................................................................
|
106 |
| Clinical Manifestations.............................................................................................................
|
108 |
| Patient Assessment.................................................................................................................
|
110 |
| Diagnostic Evaluation..............................................................................................................
|
112 |
| Treatment Modalities...............................................................................................................
|
114 |
| Nursing Management...............................................................................................................
|
117 |
| Patient and Caregiver Education............................................................................................. |
120 |
| Conclusion...............................................................................................................................
|
120 |
| References..............................................................................................................................
|
120 |
| |
|
| Chapter 5. Malignant Pleural Effusion............................................................................... |
123 |
| Introduction..............................................................................................................................
|
123 |
| Incidence..................................................................................................................................
|
123 |
| Risk Factors............................................................................................................................
|
125 |
| Pathophysiology......................................................................................................................
|
127 |
| Clinical Manifestations.............................................................................................................
|
128 |
| Patient Assessment .................................................................................................................
|
129 |
| Diagnostic Evaluation...............................................................................................................
|
130 |
| Treatment Modalities...............................................................................................................
|
135 |
| Nursing Management...............................................................................................................
|
149 |
| Patient and Caregiver Education............................................................................................. |
152 |
| Conclusion...............................................................................................................................
|
153 |
| References..............................................................................................................................
|
153 |
| |
|
| Chapter 6. Sepsis and Septic Shock................................................................................... |
159 |
| Introduction..............................................................................................................................
|
159 |
| Definitions................................................................................................................................
|
159 |
| Incidence.................................................................................................................................
|
161 |
| Risk Factors............................................................................................................................
|
162 |
| Pathophysiology......................................................................................................................
|
162 |
| Clinical Manifestations.............................................................................................................
|
165 |
| Patient Assessment.................................................................................................................
|
166 |
| Diagnostic Evaluation..............................................................................................................
|
169 |
| Treatment Modalities................................................................................................................
|
173 |
| Nursing Management...............................................................................................................
|
185 |
| Patient and Caregiver Education............................................................................................. |
190 |
| Conclusion...............................................................................................................................
|
191 |
| References..............................................................................................................................
|
191 |
| |
|
| Chapter 7. Syndrome of Inappropriate Antidiuretic
Hormone Secretion...................... |
197 |
| Introduction..............................................................................................................................
|
197 |
| Incidence.................................................................................................................................
|
197 |
| Normal Physiology of Water Regulation................................................................................... |
198 |
| Pathophysiology......................................................................................................................
|
200 |
| Risk Factors ...........................................................................................................................
|
201 |
| Clinical Manifestations.............................................................................................................
|
204 |
| Patient Assessment..................................................................................................................
|
206 |
| Diagnostic Evaluation..............................................................................................................
|
207 |
| Treatment Modalities...............................................................................................................
|
208 |
| Nursing Management...............................................................................................................
|
211 |
| Patient and Caregiver Education............................................................................................. |
215 |
| Conclusion...............................................................................................................................
|
215 |
| References..............................................................................................................................
|
216 |
| |
|
| Chapter 8. Spinal Cord Compression................................................................................. |
219 |
| Incidence..................................................................................................................................
|
220 |
| Risk Factors.............................................................................................................................
|
221 |
| Pathophysiology.......................................................................................................................
|
222 |
| Clinical Manifestations..............................................................................................................
|
229 |
| Prognostic Factors...................................................................................................................
|
234 |
| Patient Assessment..................................................................................................................
|
235 |
| Diagnostic Evaluation...............................................................................................................
|
241 |
| Treatment Modalities................................................................................................................
|
242 |
| Nursing Management...............................................................................................................
|
248 |
| Patient and Caregiver Education............................................................................................. |
255 |
| Conclusion...............................................................................................................................
|
256 |
| References..............................................................................................................................
|
256 |
| |
|
| Chapter 9. Superior Vena Cava Syndrome........................................................................ |
261 |
| Introduction..............................................................................................................................
|
261 |
| Incidence.................................................................................................................................
|
261 |
| Risk Factors.............................................................................................................................
|
263 |
| Pathophysiology......................................................................................................................
|
263 |
| Clinical Manifestations.............................................................................................................
|
266 |
| Patient Assessment..................................................................................................................
|
268 |
| Prognosis................................................................................................................................
|
269 |
| Diagnostic Evaluation..............................................................................................................
|
270 |
| Treatment Modalities ..............................................................................................................
|
271 |
| Nursing Management..............................................................................................................
|
278 |
| Patient and Caregiver Education ............................................................................................ |
281 |
| Conclusion...............................................................................................................................
|
281 |
| References..............................................................................................................................
|
282 |
| |
|
| Chapter 10. Tumor Lysis Syndrome.................................................................................... |
285 |
| Introduction..............................................................................................................................
|
285 |
| Incidence..................................................................................................................................
|
285 |
| Risk Factors.............................................................................................................................
|
286 |
| Pathophysiology.......................................................................................................................
|
289 |
| Clinical Manifestations..............................................................................................................
|
190 |
| Patient Assessment..................................................................................................................
|
292 |
| Treatment Modalities................................................................................................................
|
292 |
| Nursing Management...............................................................................................................
|
299 |
| Patient and Caregiver Education............................................................................................. |
303 |
| Conclusion...............................................................................................................................
|
304 |
| References...............................................................................................................................
|
304 |
| |
|
| Index........................................................................................................................................
|
307 |